Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
pripada skupini lijekova koji modificiraju lipide.
it belongs to a group of medicines called lipid modifying agents.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
oboje su lijekovi koji modificiraju kolesterol/lipide.
both are cholesterol/lipid modifying medicines.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
farmakoterapijska skupina: drugi pripravci koji modificiraju lipide.
pharmacotherapeutic group: other lipid modifying agents.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
farmakoterapijska skupina: drugi pripravci koji modificiraju lipide, čisti.
pharmacotherapeutic group: other lipid modifying agents, plain.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
bolesnici nisu smjeli uzimati nikakve druge antireumatske lijekove koji modificiraju tijek bolesti.
no other disease-modifying anti-rheumatic drugs were allowed.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
farmakoterapijska skupina: ostali pripravci koji modificiraju lipide, atk oznaka: c10ax14.
pharmacotherapeutic group: other lipid modifying agents, atc code: c10ax14.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
nakon toga se te t-stanice genetski modificiraju kako bi uključivale „gen samoubojicu”.
these t cells are then genetically modified to include a ‘suicide gene’.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
dapače, pravila se modificiraju u suprotnom smjeru, poput restrikcije prelaska radne snage iz novih u stare članice eu.
moreover, "reverse derogations" are being put in place, such as restrictions on labour movements from new to old eu member states.
Last Update: 2016-01-20
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
farmakoterapijska skupina: pripravci koji modificiraju lipide, drugi pripravci koji modificiraju lipide, atk oznaka: c10ax10.
pharmacotherapeutic group: lipid modifying agents, other lipid modifying agents, atc code: c10ax10.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
flixabi je indiciran za liječenje aktivnog i progresivnog psorijatičnog artritisa u odraslih bolesnika u kojih odgovor na prethodno liječenje antireumatskim lijekovima koji modificiraju tijek bolesti nije bio odgovarajući.
flixabi is indicated for treatment of active and progressive psoriatic arthritis in adult patients when the response to previous dmard therapy has been inadequate.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
za informacije o istodobnoj primjeni s antireumatskim lijekovima koji modificiraju tijek bolesti, a nisu metotreksat, vidjeti dijelove 4.4 i 5.1.
regarding combination with disease modifying anti-rheumatic drugs other than methotrexate see sections 4.4 and 5.1.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
farmakoterapijska skupina: lijekovi koji modificiraju lipide, inhibitori hmg koa reduktaze u kombinaciji s drugim lijekovima koji modificiraju lipide, atk oznaka: c10ba03
pharmacotherapeutic group: lipid modifying agents, hmg coa reductase inhibitors in combination with other lipid modifying agents, atc code: c10ba03
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
u kliničkim ispitivanjima nisu primijećene interakcije između kinereta i drugih lijekova (uključujući nesteroidne protuupalne lijekove, kortikosteride i lijekove koji modificiraju tijek bolesti).
in clinical trials, interactions between kineret and other medicinal products (including nonsteroidal anti-inflammatory medicinal products, corticosteroids, and dmards) have not been observed.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
farmakoterapijska skupina: lijekovi koji modificiraju lipide, inhibitori hmg-coa reduktaze u kombinaciji s drugim lijekovima koji modificiraju lipide, atk oznaka: c10ba04
pharmacotherapeutic group: lipid modifying substances, hmg-coa reductase inhibitors in combination with other lipid modifying substances, atc code: c10ba04
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ispitivanje je obuhvatilo 234 odrasla bolesnika s aktivnim reumatoidnim artritisom u kojih se nedjelotvornim pokazalo liječenje najmanje jednim, a najviše četirima antireumatskima lijekovima koji modificiraju tijek bolesti (dmard).
the study evaluated 234 adult patients with active rheumatoid arthritis who had failed therapy with at least one but no more than four disease-modifying antirheumatic drugs (dmards).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
benepali je u kombinaciji s metotreksatom indiciran za liječenje umjerenog do teškog aktivnog reumatoidnog artritisa u odraslih u slučaju neadekvatnog odgovora na antireumatske lijekove koji modificiraju tijek bolesti, uključivši metotreksat (osim ako je kontraindiciran).
benepali in combination with methotrexate is indicated for the treatment of moderate to severe active rheumatoid arthritis in adults when the response to disease-modifying antirheumatic drugs, including methotrexate (unless contraindicated), has been inadequate.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
cimzia se može također primjenjivati i samostalno, ako liječenje metotreksatom nije primjereno. teškog, aktivnog i progresivnog reumatoidnog artritisa koji nije prethodno liječen metotreksatom ili drugim antireumatskim lijekovima koji modificiraju tijek bolesti (dmard).
cimzia can also be given alone when treatment with methotrexate is not appropriate. severe, active and progressive rheumatoid arthritis that has not been previously treated with methotrexate or other dmards.
Last Update: 2017-04-26
Usage Frequency: 1
Quality: